Cong-Mei Wu1, Xiu-Yi Li, Tian-Hua Huang. 1. Research Center of Reproductive Medicine, Shantou University Medical College (SUMC), shantou 515041, Guangdong Province, China. cmwu@stu.edu.cn
Abstract
AIM: To construct a pEgr-IFNgamma plasmid and to investigate its expression properties of interferon-gamma (INF-gamma) induced by irradiation and the effect of gene-radiotherapy on the growth of melanoma. METHODS: A recombined plasmid, pEgr-IFNgamma, was constructed and transfected into B16 cell line with lipofectamine. The expression properties of pEgr-IFNgamma were investigated by ELISA. Then, a B16 melanoma-bearing model was established in mice, and the plasmid was injected into the tumor tissue. The tumor received 20 Gy X-ray irradiation 36 h after injection, and IFN-gamma expression was detected from the tumor tissue. A tumor growth curve at different time points was determined. RESULTS: The eukaryotic expression vector, pEgr-IFNgamma, was successfully constructed and transfected into B16 cells. IFN-gamma expression was significantly increased in transfected cells after X-ray irradiation in comparison with 0 Gy group (77.73-94.60 pg/mL, P<0.05-0.001), and was significantly higher at 4 h and 6 h than that of control group after 2 Gy X-ray irradiation (78.90-90.00 pg/mL, P<0.01-0.001). When the transfected cells were given 2 Gy irradiation 5 times at an interval of 24 h, IFN-gamma expression decreased in a time-dependent manner. From d 3 to d 15 after IFNgamma gene-radiotherapy, the tumor growth was significantly slower than that after irradiation or gene therapy alone. CONCLUSION: The anti-tumor effect of pEgr-IFNgamma gene-radiotherapy is better than that of genetherapy or radiotherapy alone for melanoma. These results may establish an important experimental basis for gene-radiotherapy of cancer.
AIM: To construct a pEgr-IFNgamma plasmid and to investigate its expression properties of interferon-gamma (INF-gamma) induced by irradiation and the effect of gene-radiotherapy on the growth of melanoma. METHODS: A recombined plasmid, pEgr-IFNgamma, was constructed and transfected into B16 cell line with lipofectamine. The expression properties of pEgr-IFNgamma were investigated by ELISA. Then, a B16 melanoma-bearing model was established in mice, and the plasmid was injected into the tumor tissue. The tumor received 20 Gy X-ray irradiation 36 h after injection, and IFN-gamma expression was detected from the tumor tissue. A tumor growth curve at different time points was determined. RESULTS: The eukaryotic expression vector, pEgr-IFNgamma, was successfully constructed and transfected into B16 cells. IFN-gamma expression was significantly increased in transfected cells after X-ray irradiation in comparison with 0 Gy group (77.73-94.60 pg/mL, P<0.05-0.001), and was significantly higher at 4 h and 6 h than that of control group after 2 Gy X-ray irradiation (78.90-90.00 pg/mL, P<0.01-0.001). When the transfected cells were given 2 Gy irradiation 5 times at an interval of 24 h, IFN-gamma expression decreased in a time-dependent manner. From d 3 to d 15 after IFNgamma gene-radiotherapy, the tumor growth was significantly slower than that after irradiation or gene therapy alone. CONCLUSION: The anti-tumor effect of pEgr-IFNgamma gene-radiotherapy is better than that of genetherapy or radiotherapy alone for melanoma. These results may establish an important experimental basis for gene-radiotherapy of cancer.
Authors: N N Hanna; S Seetharam; H J Mauceri; M A Beckett; N T Jaskowiak; R M Salloum; D Hari; M Dhanabal; R Ramchandran; R Kalluri; V P Sukhatme; D W Kufe; R R Weichselbaum Journal: Cancer J Date: 2000 Sep-Oct Impact factor: 3.360
Authors: N N Khodarev; J O Park; J Yu; N Gupta; E Nodzenski; B Roizman; R R Weichselbaum Journal: Proc Natl Acad Sci U S A Date: 2001-10-23 Impact factor: 11.205
Authors: R R Weichselbaum; D E Hallahan; M A Beckett; H J Mauceri; H Lee; V P Sukhatme; D W Kufe Journal: Cancer Res Date: 1994-08-15 Impact factor: 12.701
Authors: Vinay K Gupta; James O Park; Nora T Jaskowiak; Helena J Mauceri; Saraswathy Seetharam; Ralph R Weichselbaum; Mitchell C Posner Journal: Ann Surg Oncol Date: 2002-06 Impact factor: 5.344
Authors: L J Joseph; M M Le Beau; G A Jamieson; S Acharya; T B Shows; J D Rowley; V P Sukhatme Journal: Proc Natl Acad Sci U S A Date: 1988-10 Impact factor: 11.205